Penumbra, Inc. PEN

Company Overview

Penumbra, Inc. is a global medical technology company focused on the development and commercialization of innovative devices for the treatment of life-threatening conditions. The company primarily operates in the medical devices and interventional healthcare industries, with a strong emphasis on neurovascular, vascular, and critical care interventions. Penumbra’s products are designed to address conditions such as ischemic stroke, pulmonary embolism, deep vein thrombosis, and other vascular disorders, serving hospitals, physicians, and interventional specialists worldwide.

Founded in 2004, Penumbra has evolved from a neurovascular-focused startup into a diversified interventional device company. Its growth has been driven by internally developed technologies, physician-led innovation, and expanding clinical indications for its platforms. The company is recognized for its aspiration-based thrombectomy technologies and its emphasis on rapid, minimally invasive treatment solutions that improve patient outcomes and procedural efficiency.